FDA sets public hearing on psychedelics for September 14, Jefferies sees FDA willing to move on COMP360 Jul 13, 2026 01:04PM
TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS) Jul 13, 2026 06:26AM
H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS) Jul 9, 2026 06:49AM
Evercore ISI Upgrades Compass Pathways (CMPS) to Outperform Jul 8, 2026 09:42AM
Canaccord Reiterates Buy Rating on Compass Pathways (CMPS) Jul 8, 2026 06:49AM
View Older Stories

Jul 7, 2026 04:33PM Compass Pathways (CMPS) PT Raised to $21 at Stifel
Jul 7, 2026 03:53PM TD Cowen on Compass Pathways (CMPS): 'We think DEA reclassification to schedule 3 after approval is likely'
Jul 7, 2026 03:52PM Wolfe Research on Compass Pathways (CMPS): 'we expect the stock to regain strong momentum after this pullback'
Jul 7, 2026 12:11PM Oppenheimer on Compass Pathways (CMPS): 'Reinforced Durability Strengthens Launch Prospects'
Jul 7, 2026 12:10PM Compass Pathways (CMPS) PT Raised to $25 at BTIG, 'executed nearly flawlessly on everything within its control'
Jul 7, 2026 10:26AM Jefferies on Compass Pathways (CMPS): 'We remain 75-85%+ confident the FDA approves COMP360 (oral psilocybin) around YE:26/early 2027'
Jun 26, 2026 08:15AM Compass Pathways (CMPS) PT Raised to $20 at Canaccord
Jun 1, 2026 01:43PM TD Cowen on Compass Pathways (CMPS) Amid +10% Gain Today: 'e continue to model '360 approval in 1H27'
May 22, 2026 06:52AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
May 22, 2026 05:53AM Wolfe Research Starts Compass Pathways (CMPS) at Outperform
May 18, 2026 07:03AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
May 13, 2026 03:34PM TD Cowen Reiterates Buy Rating on Compass Pathways (CMPS)
May 13, 2026 02:33PM BTIG Reiterates Buy Rating on Compass Pathways (CMPS)
May 13, 2026 01:16PM Compass Pathways (CMPS) PT Raised to $22 at RBC Capital
May 13, 2026 06:34AM COMPASS Pathways plc (CMPS) Tops Q1 EPS by 13c
May 4, 2026 02:12AM Jefferies Starts Compass Pathways (CMPS) at Buy
Apr 28, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
Apr 24, 2026 03:41PM TD Cowen on Compass Pathways (CMPS) FDA Grant: 'meaningful positive and expected in light of last Saturday’s Executive Order'
Apr 24, 2026 01:24PM Oppenheimer on Compass Pathways (CMPS) FDA Grant: 'reinforcing our conviction considering the earlier launch timeline for COMP360 in TRD'
Apr 24, 2026 01:06PM Morgan Stanley on Compass Pathways (CMPS): 'we view today’s update as incrementally encouraging'
Apr 24, 2026 09:10AM FDA advances psychedelic drug studies for mental health treatment
Apr 24, 2026 03:49AM B.Riley Starts Compass Pathways (CMPS) at Buy
Apr 21, 2026 06:30AM Compass Pathways partners with Osmind to prepare clinics for psychedelic care
Apr 20, 2026 10:32AM BTIG stays Buy on Compass Pathways (CMPS): models may be too conservative following executive order
Apr 20, 2026 06:08AM Psychedelic stocks soar after Trump signs executive order to fast-track treatments
Apr 16, 2026 11:53AM White House Prepares Order On Ibogaine Psychedelic - CBS
Apr 14, 2026 06:30AM Compass Pathways launches grant program for COMP360 provider training
Mar 31, 2026 01:37PM COMPASS Pathways plc (CMPS) 3700 contracts of May 15 calls trade, share price up 5.8%
Mar 30, 2026 04:58PM BTIG on Compass Pathways (CMPS): 'COMP360 is shaping up as clinically meaningful'
Mar 26, 2026 06:55AM Compass Pathways (CMPS) PT Lowered to $18 at Canaccord
Mar 26, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
Mar 25, 2026 11:45AM Compass Pathways (CMPS) PT Raised to $14 at Stifel
Mar 24, 2026 04:21PM COMPASS Pathways plc (CMPS) Misses Q4 EPS by 60c
Mar 24, 2026 02:43PM Compass Pathways (CMPS) PT Lowered to $16 at Morgan Stanley
Mar 6, 2026 10:35AM COMPASS Pathways plc (CMPS) call put ratio 5.5 calls to 1 put with a focus on May 8 calls
Mar 5, 2026 01:12PM COMPASS Pathways plc (CMPS) 5K contracts of May 7 puts trade
Mar 5, 2026 10:25AM Increasing unusual put option volume: JEPI CMPS BURL EXE UAA WIX EWY JETS LWLG TAP DHT CORT CF UL SHW
Feb 26, 2026 06:30AM Compass Pathways raises $200 million from warrant exercises
Feb 18, 2026 07:30AM Compass Pathways (CMPS) PT Raised to $22 at RBC Capital
Feb 17, 2026 03:39PM COMPASS Pathways plc (CMPS) February and March 9 calls active, share price up 29%
Feb 12, 2026 07:52AM LifeSci Capital Starts Compass Pathways (CMPS) at Underperform
Jan 26, 2026 05:34AM COMPASS Pathways plc (CMPS) 3K contracts of March 8 calls trade
Jan 23, 2026 06:09AM Compass Pathways (CMPS) PT Raised to $21 at RBC Capital
Jan 8, 2026 07:50AM Compass Pathways (CMPS) Reiterated at Buy by Stifel Post COMP360 Event
Jan 8, 2026 07:47AM Compass Pathways (CMPS) Reiterated at Market Outperform by Cantor Fitzgerald
Jan 7, 2026 06:42AM Compass Pathways Announces FDA Acceptance of IND Application for PTSD
Jan 6, 2026 06:30AM Compass Pathways partners with Radial Health for mental health delivery
Dec 9, 2025 04:12PM Oppenheimer Upgrades Compass Pathways (CMPS) to Outperform
Dec 8, 2025 02:21PM COMPASS Pathways plc (CMPS) call put ratio 9.9 calls to 1 put with a focus on January 12 calls as share price up 7.7%
Nov 4, 2025 06:35AM COMPASS Pathways plc (CMPS) Misses Q3 EPS by 104c
View Older Stories